Dysregulation Of Transcription Networks Regulating Oligodendrogenesis In Age-Related Decline In CNS Remyelination

Aging Pathway
Therapeutic
Analytical
The study revealed that age-related decline in the brain’s ability to repair myelin is linked to specific changes in the genetic control systems that guide the development of myelin-producing cells.
Author

Gemini

Published

November 28, 2025

As we age, our brain’s ability to repair damaged myelin, the protective sheath around nerve fibers, naturally declines. This process, called remyelination, is crucial for recovery in conditions like multiple sclerosis, where myelin is progressively lost. When remyelination falters, it can lead to worsening disability.

Recent research has shed light on why this decline happens. Scientists investigated the intricate “transcription networks” – essentially, the control systems within cells that dictate which genes are turned on or off – that govern the creation of new myelin-producing cells, known as oligodendrocytes. These cells originate from immature cells called oligodendrocyte progenitor cells (OPCs).

By comparing the genetic activity in young and aged brains during myelin repair, the study uncovered significant age-related alterations in these transcription networks. They found that certain groups of genes, or “gene modules,” and key “transcription factors” (proteins that regulate gene expression) that are vital for OPCs to mature into myelin-forming oligodendrocytes become dysregulated with age. Interestingly, similar disruptions were observed in the brain lesions of individuals with multiple sclerosis.

The findings suggest that by understanding and potentially manipulating these specific genetic controls, we could develop new strategies to boost the brain’s regenerative capacity, offering hope for better treatments for age-related myelin repair failure and chronic demyelinating diseases.


Source: link to paper